.svg)
Holistic care = sustainable results
Yazen is a digital healthcare provider specialising in the treatment of obesity – a chronic disease that requires long-term care. Our unique model combines modern medicines with support from a full care team.
Numbers that matter
Creating value through better outcomes
At Yazen, growth is built on patient success.Our model is designed around long-term relationships, continuous care, and measurable health improvements - creating a sustainable healthcare model where better outcomes drive sustainable growth.We believe the future of obesity care is:
The Yazen Model
Combining medical expertise, digital innovation, and continuous support to help people achieve lasting health outcomes.
Obesity is a complex, chronic disease - but for too long, treatment has been fragmented. Many people are left navigating medication, nutrition, lifestyle changes, and emotional challenges on their own.The Yazen Model was created to change that.
Our evidence-based digital care model brings together doctors, dietitians, psychologists, physiotherapists, and personal YazenCoaches to provide individualised, long-term obesity treatment - all accessible through one digital platform.
More than weight loss. Complete obesity care
Successful obesity treatment requires more than a prescription or short-term intervention.
Personalised medical treatment
Every patient starts with a thorough medical assessment, including health history, blood testing, and individual risk evaluation. A dedicated doctor creates a personalised treatment plan and continuously follows progress, adjusting treatment based on each patient’s response, needs, and goals.
A multidisciplinary care team
Behind every patient is a team of specialists including:
Designed for long-term results
Many traditional weight loss approaches focus only on losing weight. The Yazen Model focuses on helping patients understand, manage, and live with obesity as a chronic condition.Through ongoing support, patients gain knowledge, tools, and confidence to build lasting habits and maintain their progress over time.
Real-world data from the Yazen Model shows strong patient adherence and an average weight reduction of approximately 16% after 12 months.
69% of Yazen patients remain in treatment after 12 months and 57% after two years, a significantly higher figure than what has been reported in previous real-world studies.
News
Stay informed with our latest news.
World Obesity Day 2026: Data afslører vedvarende skam og stigma omkring behandling af svær overvægt
Forud for World Obesity Day den 4. marts deler Yazen nye resultater fra interne patientdata, som viser, at skam og stigma fortsat er store barrierer for behandling af svær overvægt – selv i takt med at effektive medicinske behandlinger bliver mere tilgængelige.
Yazen fordobler omsætningen og fortsætter ekspansionen i Europa
I 2025 steg Yazens omsætning med 87 % til næsten €29,4 millioner, mens bruttofortjenesten fordobledes til €16,5 millioner. Virksomheden behandler nu over 37.000 aktive patienter i syv lande og overvejer yderligere ekspansion til to nye markeder i 2026. På trods af en EBITDA på –€5,7 millioner som følge af store vækstinvesteringer er Yazen fortsat en førende aktør inden for behandling af svær overvægt i Europa.